Last Updated: November 13, 2026

MILRINONE LACTATE IN DEXTROSE 5% Drug Patent Profile

« Back to Dashboard

Which patents cover Milrinone Lactate In Dextrose 5%, and what generic alternatives are available?

Milrinone Lactate In Dextrose 5% is a drug marketed by Caplin, Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, Gland, Hikma, and Hospira. and is included in ten NDAs.

The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% is milrinone lactate. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5%

A generic version of MILRINONE LACTATE IN DEXTROSE 5% was approved as milrinone lactate by FRESENIUS KABI USA on May 28^th, 2002.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for MILRINONE LACTATE IN DEXTROSE 5%?
What are the global sales for MILRINONE LACTATE IN DEXTROSE 5%?
What is Average Wholesale Price for MILRINONE LACTATE IN DEXTROSE 5%?

Summary for MILRINONE LACTATE IN DEXTROSE 5%

US Patents:	0
Applicants:	8
NDAs:	10

US Patents and Regulatory Information for MILRINONE LACTATE IN DEXTROSE 5%

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Caplin	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	219170-001	Sep 2, 2025	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Baxter Hlthcare	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075834-001	May 28, 2002	AP	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Eugia Pharma	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	209666-002	Sep 3, 2020	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075510-001	May 28, 2002		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.